Tools chosen: polymarket_direct polymarket_related kalshi_related claude_news claude_news gdelt_news earnings_data wikipedia code_execution

Sub-questions (Fermi decomposition)

Planner reasoning

This is a multi-outcome corporate M&A market where the key uncertainty is whether Paramount Skydance's hostile tender offer beats Netflix's signed agreement for WBD's studios/streaming, and whether any deal closes by June 30, 2027 (antitrust/regulatory risk). The Polymarket price on this specific outcome is the primary anchor, and current news on the WBD board decision, tender offer results, shareholder vote, and DOJ/regulatory posture will drive the estimate.

# Current state Paramount Skydance and Warner Bros. Discovery have a signed, shareholder-approved, DOJ/EU-cleared merger agreement ($31/share, ~$110B), but closing is legally paused by a stipulation barring completion until 5 days after resolution of a state-AG/WGA antitrust trial (set for March 2–19, 2027) or June 1, 2027, whichever is first. The contractual outside date is March 4, 2027, auto-extending to June 4, 2027 if only regulatory issues remain — placing resolution right at the edge of this market's June 30, 2027 deadline. # Timeline of key events - 2025-12: Netflix signs definitive agreement (~$82.7–83B) to acquire WBD studios/streaming (reported, CNBC). - 2026-02-26: Netflix declines to raise its bid; WBD board deems Paramount's offer "superior" (confirmed, CNBC/SEC filings). - 2026-02-27: Definitive Agreement and Plan of Merger signed: Paramount to acquire WBD at $31.00/share cash (~147% premium), Prince Sub Inc. merger vehicle (confirmed, SEC DEFA14A). - 2026-04-23: WBD shareholders approve the Paramount acquisition (confirmed, Wikipedia/theusaleaders.com); executive pay packages rejected same meeting. - 2026-06-12/13: DOJ clears merger without divestitures or behavioral remedies after 8-month probe (confirmed, NPR/Variety). - 2026-07 (late): EU antitrust approval granted, conditioned on Paramount ending a Universal Pictures European distribution partnership; UK opens in-depth review (confirmed/reported, CNBC, HollywoodReporter). - 2026-07-24: Paramount agrees to delay closing until June 1, 2027 (or 5 days post-trial-verdict) amid state AG/WGA lawsuits (confirmed, CNBC/HNGN/NewscastStudio). - 2026-08-04: Judge Martínez-Olguín sets single trial for both AG and WGA suits, March 2–19, 2027 (confirmed, Bloomberg/Variety). - 2026-08-17: Fact discovery opens (closes Jan 8, 2027 per proposal); Kalshi pricing ~74–78% Yes, Polymarket ~77–78% (confirmed, CNBC). - 2026-08-17 to 08-24: Paramount seeks $1.88–2B bond from plaintiff states; settlement talks reported between Paramount and CA AG Bonta over possible cable-channel divestiture (reported, Deadline/FoxBusiness/NYPost). # Event Will Paramount close its Warner Bros. Discovery acquisition (studios + streaming) by June 30, 2027? # Outcomes to forecast - Yes (Paramount closes acquisition of WBD studios/streaming by June 30, 2027) - No (does not close by that date) # Kalshi market anchor Ticker data not directly returned by kalshi_direct in this pull; cross-referenced reporting states Kalshi traders priced ~74–78% Yes as of mid-to-late August 2026 (CNBC, "1-in-4 odds of falling through"). Polymarket's mirrored market (same question) currently prices **78% Yes**, up +1.5% over 7 days and +14% over 30 days, trading range 62–86.5% over 90 days, volume ~$528.5K — a steady upward drift reflecting DOJ/EU clearance and shareholder approval outweighing litigation risk so far. # Sub-question answers 1. **Bidding contest status**: WBD's board and shareholders accepted the Paramount deal ($31/share, signed 2026-02-27, approved 2026-04-23) after Netflix declined to top Paramount's bid on 2026-02-26. Netflix's agreement is fully terminated, not a live rival bid; there is no ongoing hostile tender — this is now a friendly, board/shareholder-approved merger (CNBC, SEC filings). 2. **Shareholder/price signal**: Shareholders already approved the deal by wide margin (04-23-2026); no rival bid remains to complicate a vote. No current stock-price data was retrievable (FMP API 403 errors), but reporting says WBD trading level implies ~75% market-priced probability of completion (Yahoo Finance, via claude_news). 3. **Regulatory timeline/risk**: DOJ (June 2026) and EU (July 2026) have cleared the deal; HSR waiting period expired with no US statutory impediment. The remaining risk is the state AG + WGA antitrust suit, trial scheduled March 2–19, 2027, with an outside closing date of June 4, 2027 if only regulatory issues remain — this sits within days of the June 30, 2027 market deadline, creating meaningful timing risk (CNBC, Bloomberg). 4. **Deal protections**: Paramount raised its regulatory termination fee to $7B (from $5.8B) payable to WBD if the deal fails on regulatory grounds, and covered Netflix's $2.8B breakup fee. A "ticking fee" of $0.25/share/quarter (~$650M/quarter) accrues from Oct 2026, pressuring Paramount to close quickly; WBD can terminate for a $7B fee if not closed by the outside date (Variety, Deadline, CNBC). 5. **Trump administration/DOJ signals**: Reporting says the Trump DOJ "blessed" the deal, clearing it without conditions; NPR noted the deal installs a Trump ally (Ellison) atop CNN — a politically favorable signal for Paramount, contrasted with no comparable administration support for Netflix (NPR). 6. **Multi-outcome Polymarket distribution**: The code_execution tool's decomposition (Paramount 33%, Netflix 22%, Comcast 14%, Other 9%, None 23%) is explicitly labeled **illustrative/hypothetical**, not live data — polymarket_related found zero matching WBD/Paramount/Netflix markets, so this breakdown should be disregarded as unverified. # Key facts (high-confidence, factual) 1. [SEC/CNBC] Merger agreement signed 2026-02-27 at $31/share; shareholders approved 2026-04-23. 2. [NPR/Variety] DOJ cleared merger unconditionally 2026-06-12/13; EU approved late July 2026 with a distribution-divestiture condition. 3. [CNBC/Bloomberg] Closing stayed until June 1, 2027 (or post-trial) per stipulation; trial set March 2–19, 2027. 4. [Variety/Deadline] Paramount's regulatory break fee is $7B; ticking fee ~$650M/quarter from Oct 2026. 5. [Wikipedia] Contractual outside date March 4, 2027, extending to June 4, 2027 if only regulatory hurdles remain. # Cross-market signals - Kalshi related: no directly matched related markets found by kalshi_related tool. - Polymarket (this event, mirrored): 78% Yes, rising trend, $528K volume — direct anchor. - Reported cross-market: CNBC/Yahoo cite separate Kalshi WBD-acquisition market at ~74-78% Yes / ~22-25% No as of Aug 2026, consistent with Polymarket. # Analyst opinions and speculation - Paramount (Ellison, Q2 2026 call): "fully expect the transaction to close," confident of trial win but open to settlement. - CA AG Bonta: open to settlement only with "structural," not "behavioral," remedies (divestitures of cable assets floated). - Some reports (Newsom, Becerra) suggest political pressure toward pre-trial settlement, which could accelerate closing before June 30, 2027. - Paramount threatening relocation from California, seen by critics (Bonta) as pressure tactic/"blackmail." # Directional lean per outcome - **Yes**: Deal fully signed, shareholder-approved, DOJ/EU cleared; strong financial incentive (ticking fee, $7B fee) to close fast; possible settlement path could clear the trial obstacle before deadline; market (Polymarket/Kalshi) trending up to ~78%. - **No**: Trial doesn't conclude until March 19, 2027, then appeals/injunctions possible; outside date could lapse June 4, 2027 if only regulatory issues remain — leaving razor-thin margin before June 30, 2027; adverse trial verdict or drawn-out settlement negotiation could push closing past deadline. # Gaps / unknowns - No live WBD/PARA stock price data obtained (FMP 403 errors) to gauge market-implied merger-arb spread. - No confirmed outcome/likelihood of trial or settlement negotiations as of latest data (August 2026). - UK CMA in-depth review status/timeline unclear — could add additional delay risk not fully captured in US-focused reporting. # Calibration anchors - Polymarket YES price (this market): 78% (anchor), up from 62% low over 90 days. - Reported Kalshi analog: ~74–78% Yes / ~22-25% No (Aug 2026, CNBC). - Precedent: large contested media mergers with DOJ clearance but pending state/private antitrust litigation (e.g., past cable/telecom mergers) have historically closed within 6–12 months of trial resolution, but tight outside-date windows (here, within 1 month of the March trial's conclusion to the March/June contractual dates) increase timing risk.

1. Both forecasters anchor almost mechanically on the Polymarket/Kalshi ~74-78% price without independently stress-testing the "outside date" mechanics — specifically, neither addresses what happens if the outside date lapses June 4, 2027 and WBD chooses to exercise termination rights for the $7B fee rather than extend, which is a binary contractual risk not just a "delay" risk that could flip Yes to a hard No regardless of eventual trial outcome. 2. Neither forecast meaningfully engages with the appeal risk explicitly flagged in the brief ("adverse trial verdict or drawn-out settlement negotiation could push closing past deadline") — if the March 2027 trial produces an unfavorable ruling for Paramount, an appeal or injunction could extend well past June 30, 2027, and this tail scenario deserves more explicit probability weight than a generic "residual" mention. 3. Both cite the CA AG Bonta settlement talks as bullish for Yes, but the brief notes Bonta is open only to "structural" (divestiture) remedies, which could itself introduce a second layer of negotiation/execution delay (agreeing to and unwinding cable-asset divestitures) that neither forecaster models as a separate timing risk distinct from the trial itself. 4. The UK CMA in-depth review is flagged as an unresolved gap ("status/timeline unclear... could add additional delay risk not fully captured") — both forecasts mention it only in passing as one of several tail risks, without asking whether a CMA prohibition or extended Phase 2 review could independently block closing even if the US litigation resolves favorably. 5. Both forecasts converge tightly around the market price (78% and 76%) with minimal daylight, essentially deferring to consensus rather than independently probing whether the "narrow window" logic (trial ends March 19, stay lifts ~5 days later or June 1, outside date June 4, market deadline June 30) is actually a knife-edge scenario the market may be under-pricing — a wider spread or lower Yes probability could be justified given how many sequential steps (verdict, no appeal/injunction, no settlement collapse, UK clearance, actual closing mechanics for a $110B deal) must all resolve favorably within roughly 12 weeks. 6. Neither forecaster addresses the mechanical/operational closing timeline for a ~$110B transaction — even absent legal obstacles, arranging financing, satisfying customary closing conditions, and executing a deal of this size within days of the stay lifting (especially if resolution comes near the June 1 date) could itself risk slipping past June 30, a logistical risk distinct from the legal/regulatory risks both forecasts focus on.

74% (64% confidence)

Yes: 74% No: 26%

The deal is signed, shareholder-approved, and cleared by DOJ and the EU, with powerful economic incentives ($650M/quarter ticking fee, $7B break fee) and political tailwinds pushing toward completion, which is why both markets sit at 74-78% Yes. However, the red team is right that the residual risk is not a smooth 'delay' distribution but a stack of sequential knife-edge conditions: the stay only lifts June 1 (or 5 days post-verdict, and a bench ruling could well arrive after March), leaving roughly four weeks to execute a $110B closing before June 30; an adverse ruling or injunction, a structural-divestiture settlement requiring negotiation and execution, an unresolved UK CMA Phase 2, or a June 4 outside-date lapse each independently blocks Yes. WBD exercising termination for $7B over a $31/share cash deal is unlikely (shareholders prefer the merger), so that specific tail is small, but the compounded timing risk justifies sitting modestly below the market anchor rather than at it. I settle at 74% Yes, slightly under both forecasters and the Polymarket 78%, reflecting under-priced logistical/appeal timing risk without overriding the strong, rising market consensus.

Total pipeline time: 249.9s